Cannabis Isolates Cross Over to Pharmaceutical-Grade Products Are More Prevalent Than Ever
Financialnewsmedia.com News Commentary
PALM BEACH, Fla., Jan. 26, 2021 /PRNewswire/ In the recent years the use of CBD products have grown exponentially. They have become an everyday item in most people lives. In drug and food stores, you see CBD infused items next to the candy section and infused gummy bears in the vitamin sections. The consumer demand for CBD products and their results is only going to continue to grow. The public is now also starting to enter the next learning stage where they will discover that not all CBD products are the same. Basically there are two forms: Full-Spectrum CBD and Isolate CBD. Both Full-Spectrum CBD and CBD isolate are extracts from the cannabis plant, but even though they come from the same plant, there are still differences. Full-spectrum CBD products contain small amounts of other cannabinoids, like THC, as well as flavonoids and terpenes and ca
Rapid Therapeutic Hires Pharmaceutical Industry Authority to Oversee Labs
Rapid Therapeutic Hires Pharmaceutical Industry Authority to Oversee Labs
DALLAS, Jan. 26, 2021 Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on employing Metered Dose Inhaler (MDI) technology to deliver non-psychoactive cannabinoid compounds, announced today that it has hired Dr. Duane Drinkwine, Ph.D., to oversee all laboratory operations for the Company.
Dr. Drinkwine comes to RTSL with 30+ years of experience in the pharmaceutical industry. He has significant experience in isolate crystallization. For the last 5 years he worked as a consulting engineer for multiple laboratory equipment manufacturers in both “Big Pharma” and the hemp industry. For 10+years he worked for GlaxoSmithKline as a Laboratory Reactor Scientist in the process safety group and scale up chemistry.
Farlong Pharmaceutical Offers Contract Manufacturing Services for the Natural and Dietary Supplement and Personal Care Product Industries
Share Article
Plant-based company produces both client-specific formulas and also develops custom-made formulas and products based on a brand’s specific needs
Farlong manufactures Sylvapure Cosmetic line, containing many herbs that help increase skin elasticity, moisture, have anti-aging effects and more. WALNUT, Calif. (PRWEB) January 18, 2021
Farlong Pharmaceutical, a vertically integrated, plant-based ingredient and supplement company offers contract manufacturing services for brand owners in the natural and dietary supplement and personal care product industries.
Through six of its co-owned pharmaceutical grade GMP facilities, Farlong provides contract-manufacturing services for clients to develop plant-based, all-natural products and supplements including pharmaceutica
BrainStorm Issues 2020 Letter to Shareholders
USA - English
Share this article
Share this article
NEW YORK, Dec. 28, 2020 /PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the following letter from its Chief Executive Officer, Chaim Lebovits, to its shareholders and the investment community.
Dear Valued Shareholders,
I am incredibly proud of the tremendous progress BrainStorm made as a company in 2020. The many scientific and corporate milestones we have achieved this year are a testament to the talent and unwavering commitment of our employees, partners and investigators. I deeply appreciate the work they ve done, and their ability to execute in this challenging COVID environment. I want to thank especially the patients and caregivers, who showed a steadfast dedication to our clinical trials despite the pandemic. We remain committed to bringing NurOwn® to patients wi
To embed, copy and paste the code into your website or blog:
What You Need to Know: Late on December 11, 2020, the Food and Drug Administration issued the first emergency use authorization (“EUA”) for a vaccine for the prevention of COVID-19 in individuals 16 years of age and older. Under the EUA, the Pfizer-BioNTech COVID-19 Vaccine can be distributed in the U.S. and shipment has begun this weekend.
The scope of the EUA is limited as follows:
Pfizer Inc. will supply Pfizer-BioNTech COVID‑19 Vaccine either directly or through authorized distributor(s), who will distribute to emergency response stakeholders as directed by the U.S. government, including the Centers for Disease Control and Prevention (“CDC”) and/or other designee, for use consistent with the terms and conditions of this EUA;